Inotiv Executive and Leadership Team

Robert Leasure, the Chief Executive Officer & President at Inotiv, directs the overarching corporate strategy and operational execution. Leasure guides the company's mission to provide deep expertise and scientific capabilities across the discovery and continuum, supporting clients from early discovery through investigational new drug (IND) applications and beyond. This leadership ensures Inotiv delivers a superlative client experience, leveraging its long history and deep experience with critical research models. The focus remains on attentive, decisive service, prioritizing every program and reinforcing Inotiv's impeccable regulatory history and world-class scientific team. Robert Leasure drives the company's commitment to on-time quality data delivery, solidifying its position as a right-sized CRO for complex research projects and ensuring sustained growth and market leadership.

John Beattie, the Chief Operating Officer at Inotiv, oversees the day-to-day operational functions and ensures seamless execution of client projects. Beattie's responsibilities encompass managing the integration of scientific capabilities and research models, critical for supporting clients from discovery through IND stages. This role is pivotal in maintaining Inotiv's commitment to delivering a superlative experience by ensuring efficient resource allocation and operational excellence across all departments. By focusing on attentive, decisive service, John Beattie ensures that every program receives priority attention, directly contributing to the company's long and impeccable regulatory history. The Chief Operating Officer's leadership reinforces the world-class team of scientists and drives the consistent, on-time delivery of quality data, positioning Inotiv as a trusted CRO partner.

Lizanne Muller, the Group President, RMS at Inotiv, leads the critical research models division, a cornerstone of the company's service offering. Muller directs the supply and management of essential research models, including rodents, rabbits, and nonhuman primates, ensuring clients have access to high-quality resources for their discovery and IND-enabling studies. This leadership ensures the integrity and availability of these vital components, directly supporting Inotiv's mission to deliver a superlative experience from the beginning of discovery. Lizanne Muller's expertise is fundamental to maintaining Inotiv's long history and deep experience in this specialized area, reinforcing the company's position as a right-sized CRO. The Group President, RMS drives operational excellence within this division, contributing significantly to the on-time quality data delivery that clients depend on.

Alison Bendele, the Founder and President of Bolder BioPATH at Inotiv, spearheads specialized bio-pathology services, enhancing Inotiv's comprehensive scientific capabilities. Bendele's leadership ensures the integration of advanced pathology expertise, supporting clients through critical stages of drug development and regulatory submissions. This role is integral to Inotiv's mission of providing deep expertise across the discovery continuum, from initial research to investigational new drug (IND) applications and beyond. Alison Bendele's vision drives the delivery of a superlative experience by offering specialized insights and robust scientific support. The Founder and President of Bolder BioPATH's dedication to meticulous scientific practice reinforces Inotiv's commitment to on-time quality data delivery and its reputation for scientific rigor.

Jeffrey Krupp, the Chief Human Resources Officer at Inotiv, architects the human capital strategy to support the company's scientific and operational objectives. Krupp manages talent acquisition, development, and retention, ensuring Inotiv maintains its world-class team of scientists and dedicated service professionals. This role is crucial for fostering a culture that supports deep expertise and scientific capabilities across the discovery continuum. By aligning HR initiatives with the company's mission, Jeffrey Krupp ensures that personnel are equipped to deliver a superlative client experience and drive the success of research programs. The Chief Human Resources Officer's focus on employee engagement and development directly contributes to Inotiv's ability to provide attentive, decisive service and uphold its impeccable regulatory history, reinforcing the company's standing as a premier CRO.